ACE and myocardial infarction: As the most potent bioactive molecule involved in the classic angiotensin-converting enzyme-Angiotensin II-Angiotensin II type 1 receptor (ACE-AngII-AT1R) axis, AngII ensures the development of pathological cardiac remodeling upon myocardial infarction (MI) [6].